DCL Statistics
Total Valuation
Cuu Long Pharmaceutical JSC has a market cap or net worth of VND 1.88 trillion. The enterprise value is 2.37 trillion.
Market Cap | 1.88T |
Enterprise Value | 2.37T |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Cuu Long Pharmaceutical JSC has 73.04 million shares outstanding. The number of shares has decreased by -0.05% in one year.
Shares Outstanding | 73.04M |
Shares Change (YoY) | -0.05% |
Shares Change (QoQ) | -0.10% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 29.55.
PE Ratio | 29.55 |
Forward PE | n/a |
PS Ratio | 1.56 |
PB Ratio | 1.29 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.40, with an EV/FCF ratio of -13.66.
EV / Earnings | 37.22 |
EV / Sales | 1.96 |
EV / EBITDA | 21.40 |
EV / EBIT | 32.58 |
EV / FCF | -13.66 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.47.
Current Ratio | 2.22 |
Quick Ratio | 1.38 |
Debt / Equity | 0.47 |
Debt / EBITDA | 6.34 |
Debt / FCF | -4.05 |
Interest Coverage | 2.49 |
Financial Efficiency
Return on equity (ROE) is 4.35% and return on invested capital (ROIC) is 2.19%.
Return on Equity (ROE) | 4.35% |
Return on Assets (ROA) | 2.00% |
Return on Capital (ROIC) | 2.19% |
Revenue Per Employee | 1.32B |
Profits Per Employee | 69.64M |
Employee Count | 930 |
Asset Turnover | 0.53 |
Inventory Turnover | 2.57 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.69% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +12.69% |
50-Day Moving Average | 26,285.00 |
200-Day Moving Average | 26,351.50 |
Relative Strength Index (RSI) | 42.28 |
Average Volume (20 Days) | 480,955 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cuu Long Pharmaceutical JSC had revenue of VND 1.21 trillion and earned 63.65 billion in profits. Earnings per share was 871.45.
Revenue | 1.21T |
Gross Profit | 219.94B |
Operating Income | 72.74B |
Pretax Income | 79.57B |
Net Income | 63.65B |
EBITDA | 110.72B |
EBIT | 72.74B |
Earnings Per Share (EPS) | 871.45 |
Balance Sheet
The company has 232.17 billion in cash and 702.07 billion in debt, giving a net cash position of -469.89 billion or -6,433.29 per share.
Cash & Cash Equivalents | 232.17B |
Total Debt | 702.07B |
Net Cash | -469.89B |
Net Cash Per Share | -6,433.29 |
Equity (Book Value) | 1.48T |
Book Value Per Share | 20,037.81 |
Working Capital | 822.17B |
Cash Flow
In the last 12 months, operating cash flow was 32.82 billion and capital expenditures -206.24 billion, giving a free cash flow of -173.41 billion.
Operating Cash Flow | 32.82B |
Capital Expenditures | -206.24B |
Free Cash Flow | -173.41B |
FCF Per Share | -2,374.21 |
Margins
Gross margin is 18.19%, with operating and profit margins of 6.01% and 5.18%.
Gross Margin | 18.19% |
Operating Margin | 6.01% |
Pretax Margin | 6.58% |
Profit Margin | 5.18% |
EBITDA Margin | 9.16% |
EBIT Margin | 6.01% |
FCF Margin | -14.34% |
Dividends & Yields
Cuu Long Pharmaceutical JSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.05% |
Shareholder Yield | 0.05% |
Earnings Yield | 3.38% |
FCF Yield | -9.22% |
Stock Splits
The last stock split was on August 4, 2016. It was a forward split with a ratio of 1.4.
Last Split Date | Aug 4, 2016 |
Split Type | Forward |
Split Ratio | 1.4 |
Scores
Cuu Long Pharmaceutical JSC has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.47 |
Piotroski F-Score | n/a |